Concepedia

Karim Azer

KA

Statistics

Publications

9

Citations

256

H-Index

9

Active since

2005

Affiliations

Sanofi (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Courant Institute of Mathematical Sciences

Renewable Energy Systems (United States)

Karim Azer is an author at Sanofi (United States) specializing in physiology, atherosclerosis, and medicine.

ORCID

Top concepts

Publications per year

2005–2023

9

Publications

9

A One-dimensional Model of Blood Flow in Arteries with Friction and Convection Based on the Womersley Velocity Profile

Karim Azer, Charles S. Peskin · Cardiovascular Engineering An International Journal · 2007 · 83 citations

, , +11

Quantitative Systems Pharmacology Modeling of Acid Sphingomyelinase Deficiency and the Enzyme Replacement Therapy Olipudase Alfa Is an Innovative Tool for Linking Pathophysiology and Pharmacology

Chanchala Kaddi, Bradley Niesner, Rena Baek et al. · CPT Pharmacometrics & Systems Pharmacology · 2018 · 34 citations · Full text

Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study

Lucy Finnigan, Mark Philip Cassar, Margaret James Koziel et al. · EClinicalMedicine · 2023 · 34 citations · Full text

Quantifying cholesterol synthesis in vivo using 2H2O: enabling back-to-back studies in the same subject

Stephen F. Previs, Ablatt Mahsut, Alison Kulick et al. · Journal of Lipid Research · 2011 · 25 citations · Full text

, , +13

A Quantitative Systems Pharmacology Model of Gaucher Disease Type 1 Provides Mechanistic Insight Into the Response to Substrate Reduction Therapy With Eliglustat

Ruth E. Abrams, Chanchala Kaddi, Mengdi Tao et al. · CPT Pharmacometrics & Systems Pharmacology · 2020 · 24 citations · Full text

1–5 of 9